GSK3B and ovarian cancer: Notably, TDZD-8-mediated GSK-3β inhibition induced cell death and reduced the growth of different tumor types, including colorectal cancer [64], leukemia [65], glioblastoma [66], prostate cancer [67], and ovarian cancer [68].